Value-based health care requires a balancing of medical outcomes with economic value. Administrators need to understand both the clinical and the economic effects of potentially expensive simulation programs to rationalize the costs. Given the often-disparate priorities of clinical educators relative to health care administrators, justifying the value of simulation requires the use of economic analyses few physicians have been trained to conduct. Clinical educators need to be able to present thorough economic analyses demonstrating returns on investment and cost-effectiveness to effectively communicate with administrators.
At the 2017 Academic Emergency Medicine Consensus Conference "Catalyzing System Change through Health Care Simulation: Systems, Competency, and Outcomes," our breakout session critically evaluated the costbenefit and return on investment of simulation. In this paper we provide an overview of some of the economic tools that a clinician may use to present the value of simulation training to financial officers and other administrators in the economic terms they understand. We also define three themes as a call to action for research related to cost-benefit analysis in simulation as well as four specific research questions that will help guide educators and hospital leadership to make decisions on the value of simulation for their system or program.
A ll health care providers want to provide high-quality care to their patients. Simulation-based training has been shown to improve health care quality and reduce errors. 1, 2 Clinicians and medical educators have focused on benefits to learners and patients with little consideration of the potential economic impacts on larger health care systems. The current economic climate requires educators to effectively communicate the value to of simulation training, identifying when and how simulation is economically advantageous. 3 Few simulation research studies report any economic analysis in conjunction with their educational findings. A 2013 literature review found only 6.1% of studies (59 studies) reported on any sort of cost element, and a mere 1.6% of studies (15 studies total) compared costs with another instructional approach. 4 A search from May 2011 to May 2017 of PubMed, Embase, Scopus, Web of Science, and Cochrane using the search terms "education," "professional/ methods," "computer simulation," "computer-assisted instruction," "manikins," "simulation training," "economics," "costs," "cost analysis," or "ROI or return on investment" identified 30 new abstracts. Of these, there were only five new studies directly reporting costs. [5] [6] [7] [8] [9] Three studies performed cost comparison analysis. 3, 10, 11 Reported costs included materials, equipment costs, facility space, and personnel time.
The literature documenting the return on investment (ROI) for simulation in health care is currently limited. Fortunately, there are increasing data on the value of simulation in medical education, patient safety, and procedural proficiency. 12 Illustrating to hospital leadership the relative cost of errors and complications (especially those amenable to reduction by simulation training) to the cost of simulation is a powerful tool. 13 Educators, however, must fully appreciate of the widely variable cost of simulation, which can range from the simplistic and inexpensive, (i.e., using couch pillows to practice chest compressions) to the complex and expensive, such as high-fidelity mannequins, which can realistically simulate patient physiologic changes and permit procedural practice. Clearly, the benefit of the simulation to the learner can also vary with the fidelity of the simulation. Cost-to-benefit research is needed to show which level of complexity demonstrates the best ROI.
The purpose of this paper will serve as a primer to help clinicians and simulation experts understand how economic evaluations can help to justify investments in simulation training. In addition, the article will describe a research agenda to help define and identify applications of simulation-based training and programs that yield the most effective outcomes to help justify resource utilization to improve patient care. These recommendations were developed from input gained in the breakout session on "Communicating Value in Simulation: Cost Benefit Analysis and Return on Investment" at the 2017 Academic Emergency Medicine Consensus Conference "Catalyzing System Change through Health Care Simulation: Systems, Competency, and Outcomes." A summary of the existing literature was presented to the participants at the breakout session and cost-benefit analysis (CBA) gaps and future research questions were identified. The participants discussed the themes and future research questions and consensus was achieved, recorded, and transcribed for accuracy.
WHAT IS AN ECONOMIC EVALUATION?
An economic evaluation compares the (monetary) cost of a health care resource relative to its outcomes. Outcomes can be either health based or economic. A full economic evaluation formally assesses both resources consumed and outcomes produced. Figure 1 illustrates a recommended step-by-step evaluation process. In each of these three steps, the values of some items are difficult to quantify while some items are even difficult to identify.
Outcomes and resources must be quantified using appropriate metrics. Both identification and measurement of the resources used and measurement of the hoped-for outcomes may be dependent on the perspective and time frame of the study. For comparative purposes, many outcomes can be converted into economic terms, but defining the economic value of a health outcome can be problematic. For example, blood pressure interventions could be quantified as the reduction (in mmHg) per monetary unit spent or instead could be quantified as the monitory value of the potential increase in length expectancy per monetary unit spent. While there exists a robust literature (outside the scope of this paper) on valuing length and quality of human life in economic terms such as the QALY and the HRQL, the measurement of lost opportunity costs and the value quality of life or life expectancy remains challenging for simulation experts.
Types of Healthcare Evaluations
There are host of different economic evaluations that can illuminate the effectiveness of each dollar spent on healthcare. However, it is useful to first decide if a full formal economic analysis is needed, or if only a partial analysis would suffice. A full (or formal) economic analysis requires that at least two dimensions be considered. The first dimension is the number of Step-by-step process required for valuation of resources and economic outcomes.
alternatives being considered. The other dimension is costs per outcome. If only one alterative is considered, or if several alternatives are considered by cost or outcome alone, the evaluation need only be a partial economic evaluation (see Figure 2) . A full, formal economic analysis is necessary only if two or more alternatives are considered and if both cost and outcome information is available. However, even in this case, a full, formal economic analysis is not always required or warranted. For example, if for a given cost a more effective medical service is available, there is little need for an economic evaluation. Furthermore, when a new medical service costs less than the current medical service, and the outcomes are better or at least noninferior, then again no further economic evaluation is necessary.
WHEN IS A FULL, FORMAL ECONOMIC ANALYSIS REQUIRED?
A full, formal economic analysis is warranted when it is necessary to weigh the cost of an alternative method against a varied set of potential outcomes, specifically, if there are better outcomes for a higher cost or when a lower cost results in worse outcomes it may be worthwhile to learn how much more the cost is for the how much better an outcome or how much money could be saved for outcomes that are, technically, worse but manageable (Table 1) .
Perspective and Time
An economic evaluation is conducted from a variety of perspectives, including those of providers, payers, patients, or society as a whole. Therefore, it is important to state from whose perspective any given study is coming from to allow readers to better understand the values of a given position. To illustrate the different values by perspective (Sidebar 1), consider the following example. A standard medical treatment may be effective and cost "X" while taking time "Z" for full recovery. An alternative treatment is just as effective, but costs more, although the time for full recovery is shorter. From a payer's perspective, the preferred Money spent is what economists call "direct resources expended," but the associated "indirect costs" should also be considered. Indirect costs include "lost opportunity costs," the cost for the space occupied by the Center, and more (see Sidebar 1). Ideally, an economic evaluation should include indirect costs, as well as the potential (indirect) savings from events which did not occur (such as central line infections or pneumothorax) because of the simulation. However, during a formal evaluation, the perspective will determine which if any of the indirect costs are included. For example, from a payer's (insurer's) perspective, only direct medical expenditure (payment for claims) is considered; the price for the service is deemed to include an overhead that includes the indirect costs of running the business. From a societal perspective, both should be specified. 
VALUATION/MEASUREMENT OF OUTCOMES
1,2 Some suggested outcomes, below, can be used to value for simulation outcomes.
Simulation Outcomes
Choosing the right outcome to measure is important to an economic analysis. In recent years, there has been a trend toward "patient-valued outcomes" rather than purely statistical differences.
14 For economic analysis, both cost and "patient-valued outcomes" can be considered. As depicted in Table 2 , they can be further classified into economic outcomes and clinical outcomes.
Cost Avoidance Outcomes
Simulation-based education and intervention can provide significant cost savings in medical care. 13 Hospital readmissions are a well-established quality metric and known to be multifactorial in origin. When implementation of peer-reviewed protocols or treatment algorithms are achieved through simulation, "bounce backs" or readmission rates can potentially be reduced. An assessment of central line placement, 13 airway management, and hand washing training, among many others, can produce reductions in hospital acquired infections and improvements in patient care. These interventions can also produce a reduction readmission rates when modeling or simulation is used to build prevention protocols and treatment algorithms.
Most errors in crisis situations are often not related to a lack of knowledge, rather due to failures in teamwork, communication, and lack of clear leadership. 15 Specific simulation scenarios can help reduce errors in critical situations. For example, simulated airway training is beneficial 16 and teaches multiple options in management depending on the level of expertise or expected level of knowledge. This also includes complications postintubation, failure to intubate or ventilate, or constant desaturation. Crisis resource management (CRM) is frequently used in residency training and faculty development courses to help decrease human errors and improve patient outcomes. Simulation-based CRM helps optimize use of available resources and ancillary staff, increasing senses of situational awareness which yields improvements in decision making in high-stakes situations.
The cost of medical malpractice in the United States is estimated to be $55 billion a year, which represents about 2.4% of annual health care spending. 17 Simulation can play a crucial role in helping prevent errors by implementing treatment algorithms. 18, 19 As medicine becomes an increasingly complex field, the ability to practice low-volume, high-stakes procedures in a safe simulated environment becomes critical. 19 In the event an error does occur it is clear that an honest, thoughtful disclosure of the event is beneficial for the health care provider the patient and the family. A simulation education program for such disclosures can prove helpful in guiding such conversations. 20 Patient satisfaction is becoming a more prominent component of the overall health care quality picture. Simulated training on effective communication techniques and tips for interactions with patients can improve patient satisfaction. More data are needed to specifically determine efficacy, however, many locations practice short supervised scenarios to implement actions that may objectively demonstrate improved patient satisfaction scores.
Analysis
Return on investment analysis measures the efficiency of investment and is a subcategory of CBA comparing the intervention cost and the intervention-generated benefit (in monetary unit). It is a useful tool for decision-making regarding allocation of scarce resources. The standard ROI was calculated with the following equation. ROI = (net benefits/costs) 9 100 where net benefits = benefits-costs. For a decision maker, an intervention or a project is determined to be beneficial if ROI > 0.
An Example
Cohen and colleagues 13 conducted an economic evaluation of a simulation-based training for inserting a central venous catheter (CVC). The control group did not receive simulation training. They chose both clinical and economic outcomes. The clinical outcome was the catheter-related bloodstream infection (CRBSI) rate in the medical intensive care unit. The economic outcome was the intervention cost (the cost of simulation training) and the direct medical cost of treating CRBSI. The direct medical cost was obtained from hospital cost accounting data. All costs were adjusted to 2008 U.S. dollar.
This study showed the group trained with simulation had fewer CRBSIs. In economic terms, this demonstrated "higher effectiveness." The direct costs were calculated from the cost of simulation training and the average cost of treating CRBSIs. The Economic Typically valued in terms of "direct costs" or "direct resource use" or in terms the "costs avoided" of services or goods not used due to a successful treatment.
A study comparing two interventions to reduce central line-associated bloodstream infections (CLABSI), simulation-based mastery education for all physicians who work in an intensive care unit (ICU) versus screen-based computer training module for all ICU staff on reducing CLABSI. The outcome might look at reduction in CLABSI (clinical) or complications rates (clinical) or "costs avoided" if one intervention reduces the number of days in the ICU. The best economic outcome would be the one with the fewest unnecessary ICU days compared to the cost of implementation, simulation-based training cost, or screen-based computer training development cost.
Clinical
Typically those sorts of outcomes reported in trials: pain reduction, mortality, further morbidity, or increased mobility.
Code teams trained in a simulated environment focused on the Advanced Cardiac Life Support (ACLS) algorithm and crisis resource management skills improved return of spontaneous circulation and survival to hospital discharge compared to ACLS training alone.
simulation-trained group had 9.95 fewer CRBSIs compared to the control group. Those 9.95 CRBSIs would have cost the hospital $823,164 to treat, for which the hospital would not have been reimbursed. The direct cost of simulation training was $111,916. Therefore, the CBA coupled with the benefit-cost ratio (BCR = benefit/intervention cost) demonstrates a good ROI. In economic terms, ROI is the (net benefit/intervention cost) 9 100. This is the same as the ((benefit-intervention cost)/intervention cost)) 9 100. Doing the math, the BCR was 7.4($823,164/ $111,916) and ROI was 640% (($823,164-$111,916)/ $111,916) 9 100). The criteria for decision makers are usually a BCR > 1 or a ROI of more than > 0. This study was therefore able to demonstrate to their administration that for this simulation, the cost was well worth it, and saved the hospital money.
Barriers and Challenges
While considering both the costs of an intervention as well as potential benefits makes intuitive sense within a system of fixed resources, there are several challenges to implementation. First, administrators and economic experts rarely have clinical or educational expertise and may be focused primarily on costs. Conversely, those with simulation and health care expertise generally have only limited understanding of the economics of health care and tend to look primarily at the potential benefits of an intervention. This may result in a gap that must be bridged between the proponents of simulation-based education and those responsible for allocating the finite resources available.
There are several ways that economists try to measure the value of health care interventions. The CBA is one of the most easily understood; simply put, if the benefits are greater than the costs, than an intervention is supported. However, one of the primary limitations of CBA is that the benefit must be monetized. 21, 22 There may be significant ethical concerns in attempts to financially quantify a patient's life or quality of life.
Furthermore, CBA measurements are only as good as data entered in the equations. Many assumptions must be made in estimating both the costs and benefits of an intervention. If the data entered is flawed, the results of economic measures become irrelevant and can be misleading. Further, outcomes of simulation interventions may not be known, limiting the ability to apply such metrics.
As previously discussed, there are also challenges to accurately quantifying all costs of equipment used, which may run in the tens to hundreds of thousands of dollars in up front expenses, and should be included,. Further, simulation centers often cost several millions of dollars to build, but how much of this cost should be considered for each intervention is not clear.
Patient centered outcomes can be very challenging to measure because many of these simulation centers and studies are taking place in academic centers where trainees are being exposed to many different educational initiatives and thus outcomes are subject to a number of confounders. It may be difficult to tell if the simulation alone is merely associated with improved clinical outcome and some other aspect of training is primarily contributing to the benefit.
Even when an overall compelling financial case can be made, there may be political limitations. For example, it may be that an intervention will be budgeted to one department, but the benefits may only be realized outside of this area or over an extended period of time. It will be difficult for administrators to justify the expense if the cost-benefit ratio is not favorable locally or in the short term, even if positive more globally or long term. However, the use of economic measurements may facilitate negotiation to achieve a sustainable model of training healthcare providers and improve patient care.
CONCLUSIONS: COST ANALYSIS CONSENSUS STATEMENT
The applications of simulation in healthcare are diverse and studies have shown its benefits in improving learner, patient and healthcare system outcomes. Unfortunately, with the increasing cost of healthcare, the resources required to conduct simulation, and competing priorities for clinical providers' time, it is critical to assess whether the outcomes justify the cost. Economic analysis is one of the most important tools to answer this question but there are limited studies that have completed a CBA of the application of clinical simulation. Additionally, many clinicians do not have the knowledge or expertise to conduct an economic analysis.
A diverse panel of healthcare economists, simulation directors, instructors, and both government and academic health system leaders represented the consensus breakout session. The group discussed the current state of research in the cost-benefit of simulation in healthcare as described above. At the end of the 
